{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:59:59Z","timestamp":1788566399574,"version":"build-2803163510"},"reference-count":72,"publisher":"Bentham Science Publishers Ltd.","issue":"19","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Alzheimer\u2019s disease (AD) is a widely prevalent and neurodegenerative\ndisorder that leads to dementia and mortality worldwide. Previous investigations\nhave reported the beneficial effects of physical exercise on brain function, linked\nto anti-inflammatory effects in the brain vasculature and elevated BDNF production. Empagliflozin,\na conventional antidiabetic agent, has shown potential neuroprotective properties\nin the central nervous system, evidenced by its ability to elevate BDNF and mitigate\noxidative stress and inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>In the present investigation, AD was induced in control, exercise,\nempagliflozin (10 mg\/kg BW, PO), and combined intervention groups using intrahippocampal\ninjections of an amyloid-beta (A\u03b2) prepared solution via stereotaxic\nsurgery. The therapeutic effects of each treatment, exercise alone, empagliflozin alone,\nand exercise plus empagliflozin, were studied. After 28 days, spatial memory tests were\nused to assess memory and learning. Furthermore, histopathological (H&amp;E and Congo\nred) and immunohistochemical (GFAP) analyses were performed, and the ADP\/ATP ratio\nin isolated brain mitochondria was measured by HPLC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Our results showed that the combined program of physical training and empagliflozin\ntreatment in the A\u03b2-induced AD model drastically improved cognitive functions\nand neurological parameters, including target-finding time, traveled distance, time\nspent in the target quadrant, and ADP\/ATP ratios in brain mitochondria. Additionally, it\ndiminished necrotic cell death and reduced A\u03b2 plaques but did not notably affect astrocyte\nactivity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Exercise and empagliflozin, by affecting mitochondrial energy balance and\nreducing amyloid deposition, play key roles in mitigating AD pathophysiology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The combined effects of the treatments used in this experimental method\nyielded significant improvements in cognitive functions. These findings provide a basis\nfor further clinical studies for the exploration of the synergistic impact of the aforementioned\ntherapeutic methods.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298673434008260121111535","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:38:02Z","timestamp":1774975082000},"page":"3932-3946","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the Effects of Empagliflozin Administration and Physical Training on Cognitive Functions in an Amyloid Beta-Induced Alzheimer's Rat Model"],"prefix":"10.2174","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0828-3276","authenticated-orcid":true,"given":"Helia","family":"Behrouzfar","sequence":"first","affiliation":[{"name":"Faculty of Veterinary Medicine, Science and Research Branch of Islamic Azad University, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2795-5371","authenticated-orcid":true,"given":"Pejman","family":"Mortazavi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Specialized Veterinary Science, Science and Research Branch, IslamicAzad University, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0533-2170","authenticated-orcid":true,"given":"Shokoufeh","family":"Hassani","sequence":"additional","affiliation":[{"name":"Toxicology and Diseases Group (TDG), Pharmaceutical Sciences ResearchCenter (PSRC), Tehran University of Medical Sciences (TUMS), Tehran, Iran"},{"name":"Department of Toxicologyand Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2221-7775","authenticated-orcid":true,"given":"Saeed","family":"Aghebat Bekheir","sequence":"additional","affiliation":[{"name":"Toxicology and Diseases Group (TDG), Pharmaceutical Sciences ResearchCenter (PSRC), Tehran University of Medical Sciences (TUMS), Tehran, Iran"},{"name":"Department of Toxicologyand Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2174\/0115672050350970241216072400","volume":"21","author":"Wu D.","year":"2024","unstructured":"Wu D.; Zhang B.; Chang Y.; Huang S.; Apathy associated with Alzheimer\u2019s disease. Curr Alzheimer Res  2024,21(8),527-537","journal-title":"Curr Alzheimer Res"},{"key":"ref=2","first-page":"1","volume":"24","author":"Twarowski B.","year":"2023","unstructured":"Twarowski B.; Herbet M.; Inflammatory Processes in Alzheimer \u2019 s Disease \u2014 Pathomechanism, Diagnosis and Treatment. a review Tnt J mol Sci  2023,24(7),1-28","journal-title":"a review Tnt J mol Sci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"11632","DOI":"10.3390\/ijms222111632","volume":"22","author":"Far\u00ec G.","year":"2021","unstructured":"Far\u00ec G.; Lunetti P.; Pignatelli G.; Raele M.V.; Cera A.; Mintrone G.; Ranieri M.; Megna M.; Capobianco L.; The effect of physical exercise on cognitive impairment in neurodegenerative disease: From pathophysiology to clinical and rehabilitative aspects. Int J Mol Sci  2021,22(21),11632","journal-title":"Int J Mol Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3233\/JAD-200473","volume":"76","author":"Solis E.","year":"2020","unstructured":"Solis E.; Hascup K. N.; Hascup E. R.;  Alzheimer's disease: The link between amyloid-\u03b2 and neurovascular dysfunction. J Alzheimers Dis  2020,76,1179-1198","journal-title":"J Alzheimers Dis"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"e16302","DOI":"10.1111\/ene.16302","volume":"31","author":"Villain N.","year":"2024","unstructured":"Villain N.; Michalon R.; What is Alzheimer\u2019 s disease? An analysis of nosological perspectives from the 20th and 21st centuries. Eur J Neurol  2024,31(11),e16302","journal-title":"Eur J Neurol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"e14478","DOI":"10.1111\/cbdd.14478","volume":"103","author":"Singh Y.P.","year":"2024","unstructured":"Singh Y.P.; Kumar H.; A recent update on huprine and its hybrids as a potential multifunctional agent for the treatment of Alzheimer\u2019s disease. Chem Biol Drug Des  2024,103(2),e14478","journal-title":"Chem Biol Drug Des"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"116344","DOI":"10.1016\/j.ejmech.2024.116344","volume":"269","author":"Sun G.","year":"2024","unstructured":"Sun G.; Feng Z.; Kuang Y.; Fu Z.; Wang Y.; Zhao X.; Wang F.; Sun H.; Yuan H.; Dai L.; Design, synthesis, and biological evaluation of piperazine derivatives as pan-PPARs agonists for the treatment of liver fibrosis. Eur J Med Chem  2024,269,116344","journal-title":"Eur J Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"DeTure M.A.","year":"2019","unstructured":"DeTure M.A.; Dickson D.W.; The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener  2019,14(1),32","journal-title":"Mol Neurodegener"},{"key":"ref=9","author":"Gozes I.","year":"2020","unstructured":"Gozes I.; Levine J.;  Neuroprotection in Autism, Schizophrenia and Alzheimer\u2019s Disease  2020","journal-title":"Neuroprotection in Autism, Schizophrenia and Alzheimer\u2019s Disease"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e70004","DOI":"10.1111\/cbdd.70004","volume":"104","author":"Singh Y.P.","year":"2024","unstructured":"Singh Y.P.; Prasad S.; Kumar H.; A Comprehensive Analysis on Galantamine Based Hybrids for the Management of Alzheimer\u2019s Disease. Chem Biol Drug Des  2024,104(5),e70004","journal-title":"Chem Biol Drug Des"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1089\/ars.2020.8075","volume":"34","author":"Marques-Aleixo I.","year":"2021","unstructured":"Marques-Aleixo I.; Beleza J.; Sampaio A.; Stevanovi\u0107 J.; Coxito P.; Gon\u00e7alves I.; Ascens\u00e3o A.; Magalh\u00e3es J.; Preventive and therapeutic potential of physical exercise in neurodegenerative diseases. Antioxid Redox Signal  2021,34(8),674-693","journal-title":"Antioxid Redox Signal"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41422-021-00582-x","volume":"32","author":"Pang K.","year":"2022","unstructured":"Pang K.; Jiang R.; An $\\text{App}$ knock-in rat model for Alzheimer\u2019s disease exhibiting $\\text{A}\\beta$ and tau pathologies, neuronal death and cognitive impairments. Cell Res  2022,32,157-175","journal-title":"Cell Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.20959\/wjpps20217-19427","volume":"10","author":"Anwal L.","year":"2021","unstructured":"Anwal L.; a Comprehensive Review on Alzheimer\u2019S Disease. World J Pharm Pharm Sci  2021,10(7),1170","journal-title":"World J Pharm Pharm Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mito.2010.08.009","volume":"11","author":"Tillement L.","year":"2011","unstructured":"Tillement L.; Lecanu L.; Papadopoulos V.; Alzheimer\u2019s disease: Effects of \u03b2-amyloid on mitochondria. Mitochondrion  2011,11(1),13-21","journal-title":"Mitochondrion"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"Zhang J.","year":"2024","unstructured":"Zhang J.; Zhang Y.; Wang J.; Xia Y.; Zhang J.; Chen L.; Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther  2024,9(1),211","journal-title":"Signal Transduct Target Ther"},{"key":"ref=16","first-page":"1919","author":"Number P.","year":"1920","unstructured":"Number P.; Information P.; Specification T.; Information S.; Information T.; Product information product information. Opadry  1920(14998),1919-1920","journal-title":"Opadry"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"110002","DOI":"10.1016\/j.cbi.2022.110002","volume":"362","author":"Motawi T.K.","year":"2022","unstructured":"Motawi T.K.; Al-Kady R.H.; Abdelraouf S.M.; Senousy M.A.; Empagliflozin alleviates endoplasmic reticulum stress and augments autophagy in rotenone-induced Parkinson\u2019s disease in rats: Targeting the GRP78\/PERK\/eIF2\u03b1\/CHOP pathway and miR-211-5p. Chem Biol Interact  2022,362,110002","journal-title":"Chem Biol Interact"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"8986","DOI":"10.1038\/s41598-025-93483-7","volume":"15","author":"Dai W.","year":"2025","unstructured":"Dai W.; Alavi R.; Li J.; Carreno J.; Pahlevan N.M.; Kloner R.A.; Empagliflozin demonstrates neuroprotective and cardioprotective effects by reducing ischemia\/reperfusion damage in rat models of ischemic stroke and myocardial infarction. Sci Rep  2025,15(1),8986","journal-title":"Sci Rep"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.55730\/1300-0144.5943","volume":"55","author":"Do\u011fan \u015e.E.","year":"2025","unstructured":"Do\u011fan \u015e.E.; Ku\u015fkonmaz \u015e.M.; Celepli\u0307 P.; \u015eenes M.; H\u00fcc\u00fcmeno\u011flu S.; \u00c7ulha C.; Empagliflozin effects on cyclophosphamide-induced neurotoxicity in rats without diabetes. Turk J Med Sci  2025,55(1),65-71","journal-title":"Turk J Med Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jsps.2022.03.005","volume":"30","author":"Ahmed S.","year":"2022","unstructured":"Ahmed S.; El-Sayed M.M.; Kandeil M.A.; Khalaf M.M.; Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of \u03b1-synuclein and Parkin levels in rotenone-induced Parkinson\u2019s disease in rats. Saudi Pharm J  2022,30(6),863-873","journal-title":"Saudi Pharm J"},{"key":"ref=21","volume":"26","author":"Pawlos A.","year":"2021","unstructured":"Pawlos A.; Broncel M.; Wo\u017aniak E.; Gorzelak-Pabi\u015b P.; SGLT2\/SGLT1 Canagliflozin. Molecules  2021,26(23)","journal-title":"Molecules"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.4103\/1673-5374.385865.","volume":"19","author":"Hierro-bujalance C.","year":"2024","unstructured":"Hierro-bujalance C.; Garcia-alloza M.; Empagliflozin reduces brain pathology in Alzheimer\u2019s disease and type 2 diabetes. Neural Regen Res  2024,19,1189","journal-title":"Neural Regen Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"12417","DOI":"10.3390\/cimb46110737","volume":"46","author":"Kim D.H.","year":"2024","unstructured":"Kim D.H.; Lee M.J.; Kang D.; Lee J.Y.; Park S.; Khang A.R.; Bae J.H.; Kim J.Y.; Kim S.H.; Kang Y.H.; Yi D.; Empagliflozin attenuates high-glucose-induced astrocyte activation and inflammation via NF-\u03baB pathway. Curr Issues Mol Biol  2024,46(11),12417-12427","journal-title":"Curr Issues Mol Biol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1007\/s10787-025-01755-5","volume":"33","author":"Abdel-lah E.S.","year":"2025","unstructured":"Abdel-lah E.S.; Sherkawy H.S.; Mohamed W.H.; Fawy M.A.; Hasan A.A.; Muhammed A.A.; Taha A.F.; Tony A.A.; Hamad N.; Gamea M.G.; Empagliflozin and memantine combination ameliorates cognitive impairment in scopolamine + heavy metal mixture-induced Alzheimer\u2019s disease in rats: Role of AMPK\/mTOR, BDNF, BACE-1, neuroinflammation, and oxidative stress. Inflammopharmacology  2025,33(6),3479-3498","journal-title":"Inflammopharmacology"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"177525","DOI":"10.1016\/j.ejphar.2025.177525","volume":"998","author":"Ali M.A.","year":"2025","unstructured":"Ali M.A.; Michel H.E.; Menze E.T.; Tadros M.G.; Wahdan S.A.; The potential neuroprotective effect of empagliflozin against depressive-like behavior induced by chronic unpredictable mild stress in rats: Involvement of NLRP3 inflammasome. Eur J Pharmacol  2025,998,177525","journal-title":"Eur J Pharmacol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11481-024-10162-6","volume":"20","author":"Abdelaziz H.A.","year":"2025","unstructured":"Abdelaziz H.A.; Hamed M.F.; Ghoniem H.A.; Nader M.A.; Suddek G.M.; Empagliflozin mitigates PTZ-induced seizures in rats: Modulating Npas4 and CREB-BDNF signaling pathway. J Neuroimmune Pharmacol  2025,20(1),5","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"e70704","DOI":"10.1002\/alz.70704","volume":"21","author":"Erichsen J.M.","year":"2025","unstructured":"Erichsen J.M.; Register T.C.; Sutphen C.; Ma D.; Gaussoin S.A.; Rudolph M.; Rundle M.; Bateman J.T.; Lockhart S.N.; Sai K.K.S.; Whitlow C.; Craft S.; A phase 2A\/B randomized trial of metabolic modulators intranasal insulin and empagliflozin for MCI and early AD. Alzheimers Dement  2025,21(10),e70704","journal-title":"Alzheimers Dement"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13205-025-04455-7","volume":"15","author":"Blossom V.","year":"2025","unstructured":"Blossom V.; Ullal S.D.; Repurposing the hypoglycaemic agents for neuroinflammation, a comprehensive review. 3 Biotech  2025,15(9),1-25","journal-title":"3 Biotech"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"121258","DOI":"10.1016\/j.lfs.2022.121258","volume":"312","author":"Mousa H.H.","year":"2023","unstructured":"Mousa H.H.; Sharawy M.H.; Nader M.A.; Empagliflozin enhances neuroplasticity in rotenone-induced parkinsonism: Role of BDNF, CREB and Npas4. Life Sci  2023,312,121258","journal-title":"Life Sci"},{"key":"ref=30","author":"Zachary J.F.","year":"2012","unstructured":"Zachary J.F.; McGavin M.D.;  Pathologic Basis of Veterinary Disease5: Pathologic Basis of Veterinary Disease  2012","journal-title":"Pathologic Basis of Veterinary Disease5: Pathologic Basis of Veterinary Disease"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3233\/BPL-160040","volume":"2","author":"Basso J.C.","year":"2016","unstructured":"Basso J.C.; Suzuki W.A.; The Effects of Acute Exercise on Mood, Cognition, Neurophysiology, and Neurochemical Pathways: A Review. Brain Plast  2016,2(2),127-152","journal-title":"Brain Plast"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.brainresbull.2016.03.012","volume":"125","author":"Spielman L.J.","year":"2016","unstructured":"Spielman L.J.; Little J.P.; Klegeris A.; Physical activity and exercise attenuate neuroinflammation in neurological diseases. Brain Res Bull  2016,125,19-29","journal-title":"Brain Res Bull"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jshs.2020.01.004","volume":"9","author":"De la Rosa A.","year":"2020","unstructured":"De la Rosa A.; Olaso-Gonzalez G.; Arc-Chagnaud C.; Millan F.; Salvador-Pascual A.; Garc\u00eda-Lucerga C.; Blasco-Lafarga C.; Garcia-Dominguez E.; Carretero A.; Correas A.G.; Vi\u00f1a J.; Gomez-Cabrera M.C.; Physical exercise in the prevention and treatment of Alzheimer\u2019s disease. J Sport Health Sci  2020,9(5),394-404","journal-title":"J Sport Health Sci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"104621","DOI":"10.1016\/j.nbd.2019.104621","volume":"134","author":"Gubert C.","year":"2020","unstructured":"Gubert C.; Kong G.; Renoir T.; Hannan A.J.; Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases. Neurobiol Dis  2020,134,104621","journal-title":"Neurobiol Dis"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1243869","DOI":"10.3389\/fnagi.2023.1243869","volume":"15","author":"Pahlavani H. A.","year":"2023","unstructured":"Pahlavani H. A.; Exercise therapy to prevent and treat Alzheimer\u2019s disease. Front Aging Neurosci  2023,15,1243869","journal-title":"Front Aging Neurosci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"111186","DOI":"10.3389\/fnagi.2021.617588","volume":"143","author":"Misrani A.","year":"2021","unstructured":"Misrani A.; Tabassum S.; Yang L.; Mitochondrial dysfunction and oxidative stress in Alzheimer's disease. Front Aging Neurosci  2021,143,111186","journal-title":"Front Aging Neurosci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40035-022-00279-0","volume":"11","author":"Gao L.","year":"2022","unstructured":"Gao L.; Zhang Y.; Sterling K.; Song W.; Brain-derived neurotrophic factor in Alzheimer\u2019s disease and its pharmaceutical potential. Transl Neurodegener  2022,11(1),4","journal-title":"Transl Neurodegener"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.3390\/ijms23063245","volume":"23","author":"Ribari\u010d S.","year":"2022","unstructured":"Ribari\u010d S.; Physical Exercise, a Potential Non-Pharmacological Intervention for Attenuating Neuroinflammation and Cognitive Decline in Alzheimer\u2019s Disease Patients. Int J Mol Sci  2022,23(6),3245","journal-title":"Int J Mol Sci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jagp.2015.07.007","volume":"23","author":"Str\u00f6hle A.","year":"2015","unstructured":"Str\u00f6hle A.; Schmidt D.K.; Schultz F.; Fricke N.; Staden T.; Hellweg R.; Priller J.; Rapp M.A.; Rieckmann N.; Drug and Exercise Treatment of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Effects on Cognition in Randomized Controlled Trials. Am J Geriatr Psychiatry  2015,23(12),1234-1249","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.neuro.2021.05.013","volume":"85","author":"Sanati M.","year":"2021","unstructured":"Sanati M.; Aminyavari S.; Khodagholi F.; Hajipour M.J.; Sadeghi P.; Noruzi M.; Moshtagh A.; Behmadi H.; Sharifzadeh M.; PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) ameliorate learning and memory deficit in a rat model of Alzheimer\u2019s disease: Potential participation of STIMs. Neurotoxicology  2021,85(May),145-159","journal-title":"Neurotoxicology"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00207454.2024.2342973","author":"Borikar S. P.","year":"2024","unstructured":"Borikar S. P.; Sonawane D. S.; Tapre D. N.; Jain S. P.; Exploring the neuropharmacological potential of empagliflozin on nootropic and scopolamine-induced amnesic model of Alzheimer\u2019s like conditions in rats. Int J Neurosci  2024,1-13","journal-title":"Int J Neurosci"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"116497","DOI":"10.1016\/j.taap.2023.116497","volume":"467","author":"Noruzi M.","year":"2023","unstructured":"Noruzi M.; Behmadi H.; Halvaei Khankahdani Z.; Sabzevari O.; Foroumadi A.; Ghahremani M.H.; Pourahmad J.; Hassani S.; Gholami M.; Moghimi S.; Ghazimoradi M.M.; Taghizadeh G.; Sharifzadeh M.; Alpha pyrrolidinovalerophenone (\u03b1-PVP) administration impairs spatial learning and memory in rats through brain mitochondrial dysfunction. Toxicol Appl Pharmacol  2023,467,116497","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"212827","DOI":"10.1016\/j.bioadv.2022.212827","volume":"137","author":"Khonsari F.","year":"2022","unstructured":"Khonsari F.; Heydari M.; Sharifzadeh M.; Valizadeh H.; Dinarvand R.; Atyabi F.; Transferrin decorated-nanostructured lipid carriers (NLCs) are a promising delivery system for rapamycin in Alzheimer\u2019s disease: An in vivo study. Biomater Adv  2022,137(April),212827","journal-title":"Biomater Adv"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/laban0608-271","volume":"37","author":"Cooper D.M.","year":"2008","unstructured":"Cooper D.M.; Hoffman W.; Tomlinson K.; Lee H.Y.; Refinement of the dosage and dosing schedule of ketoprofen for postoperative analgesia in Sprague-Dawley rats. Lab Anim (NY)  2008,37(6),271-275","journal-title":"Lab Anim (NY)"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3791\/880","author":"Geiger B.M.","year":"2008","unstructured":"Geiger B.M.; Frank L.E.; Caldera-Siu A.D.; Pothos E.N.; Survivable stereotaxic surgery in rodents. J Vis Exp  2008(20),20-22","journal-title":"J Vis Exp"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3390\/pathophysiology31040047","volume":"31","author":"Doumar H.","year":"2024","unstructured":"Doumar H.; El Mostafi H.; Elhessni A.; Laaziz A.; Mesfioui A.; Comparative Study of injected alzheimer's disease models in rats: Insights from experimental research. Pathophysiology  2024,31,643","journal-title":"Pathophysiology"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1037\/bne0000080","volume":"129","author":"Gallagher M.","year":"2015","unstructured":"Gallagher M.; Burwell R.; Burchinal M.; Severity of spatial learning impairment in aging: Development of a learning index for performance in the Morris water maze. Behav Neurosci  2015,129(4),540-548","journal-title":"Behav Neurosci"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.neuropharm.2019.01.030","volume":"148","author":"Pierzynowska K.","year":"2019","unstructured":"Pierzynowska K.; Podlacha M.; Gaffke L.; Majkutewicz I.; Mantej J.; W\u0119grzyn A.; Osiad\u0142y M.; My\u015bli\u0144ska D.; W\u0119grzyn G.; Autophagy-dependent mechanism of genistein-mediated elimination of behavioral and biochemical defects in the rat model of sporadic Alzheimer\u2019s disease. Neuropharmacology  2019,148(January),332-346","journal-title":"Neuropharmacology"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40035-022-00324-y","volume":"11","author":"Bonvicini G.","year":"2022","unstructured":"Bonvicini G.; Syv\u00e4nen S.; Andersson K.G.; Haaparanta- Solin M.; L\u00f3pez-Pic\u00f3n F.; Sehlin D.; ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer\u2019s disease with a bispecific, brain-penetrating fusion protein. Transl Neurodegener  2022,11(1),55","journal-title":"Transl Neurodegener"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12929-019-0524-y","volume":"26","author":"Vin\u00edcius M.","year":"2019","unstructured":"Vin\u00edcius M.; Alzheimer\u2019s disease: Risk factors and potentially protective measures. J Biomed Sci  2019,26(1),33","journal-title":"J Biomed Sci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"742408","DOI":"10.3389\/fnagi.2022.742408","volume":"14","author":"Abubakar M.B.","year":"2022","unstructured":"Abubakar M.B.; Sanusi K.O.; Ugusman A.; Mohamed W.; Kamal H.; Ibrahim N.H.; Khoo C.S.; Kumar J.; Alzheimer\u2019s disease: An update and insights into pathophysiology. Front Aging Neurosci  2022,14(March),742408","journal-title":"Front Aging Neurosci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41422-021-00582-x","volume":"32","author":"Pang K.","year":"2022","unstructured":"Pang K.; Jiang R.; Zhang W.; Yang Z.; Li L.L.; Shimozawa M.; Tambaro S.; Mayer J.; Zhang B.; Li M.; Wang J.; Liu H.; Yang A.; Chen X.; Liu J.; Winblad B.; Han H.; Jiang T.; Wang W.; Nilsson P.; Guo W.; Lu B.; An App knock-in rat model for Alzheimer\u2019s disease exhibiting A\u03b2 and tau pathologies, neuronal death and cognitive impairments. Cell Res  2022,32(2),157-175","journal-title":"Cell Res"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"e12291","DOI":"10.1002\/dad2.12291","volume":"14","author":"Shir D.","year":"2022","unstructured":"Shir D.; Graff-Radford J.; Hofrenning E.I.; Lesnick T.G.; Przybelski S.A.; Lowe V.J.; Knopman D.S.; Petersen R.C.; Jack C.R.; Vemuri P.; Algeciras-Schimnich A.; Campbell M.R.; Stricker N.H.; Mielke M.M.; Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer\u2019s disease and vascular pathology. Alzheimers Dement (Amst)  2022,14(1),e12291","journal-title":"Alzheimers Dement (Amst)"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3233\/JAD-150161","volume":"47","author":"Rudnitskaya E.A.","year":"2015","unstructured":"Rudnitskaya E.A.; Muraleva N.A.; Yi K.; Kiseleva E.; Melatonin attenuates memory impairment, amyloid- \u2424 accumulation, and neurodegeneration in a rat model of sporadic Alzheimer\u2019s disease. J Alzheimers Dis  2015,47,103","journal-title":"J Alzheimers Dis"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13024-020-0358-9","volume":"15","author":"Williams T.","year":"2020","unstructured":"Williams T.; Borchelt D.R.; Chakrabarty P.; Therapeutic approaches targeting Apolipoprotein E function in Alzheimer\u2019s disease. Mol Neurodegener  2020,15,8","journal-title":"Mol Neurodegener"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.brainres.2010.02.046","volume":"1328","author":"Li J.","year":"2010","unstructured":"Li J.; Wang C.; Zhang J.H.; Cai J.M.; Cao Y.P.; Sun X.J.; Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer\u2019s disease by reduction of oxidative stress. Brain Res  2010,1328,152-161","journal-title":"Brain Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12974-020-1698-7","volume":"17","author":"Ivanova N.","year":"2020","unstructured":"Ivanova N.; Liu Q.; Agca C.; Agca Y.; Noble E.G.; Whitehead S.N.; Cechetto D.F.; White matter inflammation and cognitive function in a co-morbid metabolic syndrome and prodromal Alzheimer\u2019s disease rat model. J Neuroinflammation  2020,17(1),29","journal-title":"J Neuroinflammation"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3233\/JAD-150161","volume":"47","author":"Rudnitskaya E.A.","year":"2015","unstructured":"Rudnitskaya E.A.; Muraleva N.A.; Maksimova K.Y.; Kiseleva E.; Kolosova N.G.; Stefanova N.A.; Melatonin attenuates memory impairment, amyloid-\u03b2 accumulation, and neurodegeneration in a rat model of sporadic Alzheimer\u2019s disease. J Alzheimers Dis  2015,47(1),103-116","journal-title":"J Alzheimers Dis"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1039\/C8FO00643A","volume":"9","author":"Che H.","year":"2018","unstructured":"Che H.; Li Q.; Zhang T.; Ding L.; Zhang L.; Shi H.; Yanagita T.; Xue C.; Chang Y.; Wang Y.; A comparative study of EPA-enriched ethanolamine plasmalogen and EPA-enriched phosphatidylethanolamine on A\u03b2  induced cognitive deficiency in a rat model of Alzheimer\u2019s disease. Food Funct  2018,9(5),3008-3017","journal-title":"Food Funct"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/01616412.2018.1544745","volume":"41","author":"Karthick C.","year":"2019","unstructured":"Karthick C.; Nithiyanandan S.; Essa M.M.; Guillemin G.J.; Jayachandran S.K.; Anusuyadevi M.; Time-dependent effect of oligomeric amyloid-\u03b2 (1\u201342)-induced hippocampal neurodegeneration in rat model of Alzheimer\u2019s disease. Neurol Res  2019,41(2),139-150","journal-title":"Neurol Res"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12974-019-1685-z","volume":"16","author":"Weekman E.M.","year":"2019","unstructured":"Weekman E.M.; Sudduth T.L.; Price B.R.; Woolums A.E.; Hawthorne D.; Seaks C.E.; Wilcock D.M.; Time course of neuropathological events in hyperhomocysteinemic amyloid depositing mice reveals early neuroinflammatory changes that precede amyloid changes and cerebrovascular events. J Neuroinflammation  2019,16(1),284","journal-title":"J Neuroinflammation"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.physbeh.2013.08.006","volume":"120","author":"Cioanca O.","year":"2013","unstructured":"Cioanca O.; Hritcu L.; Mihasan M.; Hancianu M.; Cognitive-enhancing and antioxidant activities of inhaled coriander volatile oil in amyloid \u03b2(1\u201342) rat model of Alzheimer\u2019s disease. Physiol Behav  2013,120,193-202","journal-title":"Physiol Behav"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2174\/1570159X19666210517114016","volume":"20","author":"Bhatia S.","year":"2022","unstructured":"Bhatia S.; Rawal R.; Sharma P.; Singh T.; Singh M.; Singh V.; Mitochondrial Dysfunction in Alzheimer\u2019s Disease: Opportunities for Drug Development. Curr Neuropharmacol  2022,20(4),675-692","journal-title":"Curr Neuropharmacol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mcn.2017.11.008","volume":"86","author":"Alkadhi K.A.","year":"2018","unstructured":"Alkadhi K.A.; Dao A.T.; Exercise decreases BACE and APP levels in the hippocampus of a rat model of Alzheimer\u2019s disease. Mol Cell Neurosci  2018,86,25-29","journal-title":"Mol Cell Neurosci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"111186","DOI":"10.1016\/j.exger.2020.111186","volume":"143","author":"Schimidt H.L.","year":"2021","unstructured":"Schimidt H.L.; Carrazoni G.S.; Garcia A.; Izquierdo I.; Mello-Carpes P.B.; Carpes F.P.; Strength training or green tea prevent memory deficits in a $\\beta$-amyloid peptide- mediated Alzheimer\u2019s disease model. Exp Gerontol  2021,143,111186","journal-title":"Exp Gerontol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.brainresrev.2010.11.004","volume":"67","author":"Reddy P.H.","year":"2011","unstructured":"Reddy P.H.; Reddy T.P.; Manczak M.; Calkins M.J.; Shirendeb U.; Mao P.; Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases. Brain Res Brain Res Rev  2011,67(1-2),103-118","journal-title":"Brain Res Brain Res Rev"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fnagi.2019.00311","volume":"11","author":"Chakravorty A.","year":"2019","unstructured":"Chakravorty A.; Jetto C.T.; Manjithaya R.; Dysfunctional mitochondria and mitophagy as drivers of Alzheimer\u2019s disease pathogenesis. Front Aging Neurosci  2019,11,311","journal-title":"Front Aging Neurosci"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1000839","DOI":"10.3389\/fnins.2022.1000839","volume":"16","author":"Chen X.","year":"2022","unstructured":"Chen X.; Ma L.; Zhao J.; Pan X.; Chen S.; Effect of empagliflozin on cytoskeletal repair in the hippocampus of obese mice. Front Neurosci  2022,16(November),1000839","journal-title":"Front Neurosci"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"7174","DOI":"10.3390\/molecules27217174","volume":"27","author":"Nakhal M.M.","year":"2022","unstructured":"Nakhal M.M.; Aburuz S.; Sadek B.; Akour A.; Repurposing SGLT2 inhibitors for neurological disorders: A focus on the autism spectrum disorder. Molecules  2022,27(21),7174","journal-title":"Molecules"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"5890","DOI":"10.1007\/s12035-021-02514-7","volume":"58","author":"Tan Z.X.","year":"2021","unstructured":"Tan Z.X.; Dong F.; Wu L.Y.; Feng Y.S.; Zhang F.; The beneficial role of exercise on treating Alzheimer\u2019s disease by inhibiting \u03b2-amyloid peptide. Mol Neurobiol  2021,58(11),5890-5906","journal-title":"Mol Neurobiol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"596","DOI":"10.17179\/excli2019-2082","volume":"19","author":"Molaei A.","year":"2020","unstructured":"Molaei A.; Hatami H.; Dehghan G.; Sadeghian R.; Khajehnasiri N.; Synergistic effects of quercetin and regular exercise on the recovery of spatial memory and reduction of parameters of oxidative stress in animal model of Alzheimer\u2019s disease. EXCLI J  2020,19,596-612","journal-title":"EXCLI J"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"e20601","DOI":"10.1371\/journal.pone.0020601","volume":"6","author":"Raichlen D.A.","year":"2011","unstructured":"Raichlen D.A.; Gordon A.D.; Relationship between exercise capacity and brain size in mammals. PLoS ONE  2011,6(6),e20601","journal-title":"PLoS ONE"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673434008260121111535","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/251657\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673434008260121111535","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T09:34:04Z","timestamp":1785144844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/251657\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":72,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673434008260121111535","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-09-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}